• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Moratorium on risky virology studies leaves work at 14 institutions in limbo

Shiloh

Editor, Senior Moderator
Source: http://news.sciencemag.org/biology/...ogy-studies-leaves-work-14-institutions-limbo


Moratorium on risky virology studies leaves work at 14 institutions in limbo
By
Jocelyn Kaiser
17 November 2014 3:30 pm

Like many influenza virologists, John Steel of Emory University in Atlanta often uses a feeble lab strain of influenza in his studies of how seasonal flu spreads. ?It?s a nasty virus if you?re a mouse? but doesn?t sicken humans, Steel says of this 80-year-old lab strain, known as PR8. But last month, under orders from the National Institutes of Health (NIH), Steel told his two staff members working with PR8 to put their experiments on hold and find other things to do while NIH decides whether the work falls under a temporary ban on risky virus experiments.

?Our feeling is that the likelihood [of harm from studies with the PR8 strain] is exceedingly slim,? says Walter Orenstein, who oversees Emory?s NIH-funded influenza research center. ?But it?s something for the NIH to decide.?

Last month in an unusual step, the U.S. government announced a ?pause? in federal funding for virology studies that involve tweaking influenza, MERS, and SARS viruses in ways that could make them more transmissible or pathogenic in mammals. The government encouraged everyone conducting such gain-of-function (GOF) projects to voluntarily pause while experts spend a year hashing out the risks and benefits of the studies and developing a policy for when to allow them...
 
Back
Top